Spyre Therapeutics, Inc. (SYRE) — Institutional Holders, Q2 2026
269 institutional investment managers reported a SYRE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SYRE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Paradigm Biocapital AdvisorsAdded · +1,883,512 sh+$167.2M
- VANGUARD PORTFOLIO MANAGEMENTAdded · +1,744,968 sh+$154.9M
- ADAGE CAPITAL PARTNERS GP, L.L.C.New · +1,722,300 sh+$152.9M
- Capital World InvestorsAdded · +1,648,989 sh+$146.4M
- PRICE T ROWE ASSOCIATESAdded · +1,362,125 sh+$120.9M
Biggest sellers
- Fairmount Funds ManagementSold out · -4,018,101 sh-$356.7M
- RA CAPITAL MANAGEMENT, L.P.Sold out · -1,621,620 sh-$144.0M
- Commodore CapitalTrimmed · -1,065,594 sh-$94.6M
- BAKER BROS. ADVISORSSold out · -1,000,000 sh-$88.8M
- Caligan PartnersSold out · -878,127 sh-$78.0M
SYRE 13F holders ranked 1–100 of 269
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | FMR#1 · 13,026,187 sh | 13,026,187 | $1.2B | 0.05% | +10.6% |
| 2 | BlackRock#2 · 6,506,605 sh | 6,506,605 | $577.7M | <0.01% | +17.8% |
| 3 | PERCEPTIVE ADVISORS#3 · 4,319,496 sh | 4,319,496 | $383.5M | 5.76% | +14.2% |
| 4 | RTW INVESTMENTS#4 · 4,251,996 sh | 4,251,996 | $377.5M | 3.22% | +1.9% |
| 5 | Paradigm Biocapital Advisors#5 · 3,840,778 sh | 3,840,778 | $341.0M | 6.38% | +96.2% |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 3,448,681 sh | 3,448,681 | $306.2M | <0.01% | +12.8% |
| 7 | STATE STREET#7 · 3,057,416 sh | 3,057,416 | $271.4M | <0.01% | +17.3% |
| 8 | VR Adviser#8 · 2,985,448 sh | 2,985,448 | $265.0M | 8.04% | -19.0% |
| 9 | PRICE T ROWE ASSOCIATES#9 · 2,960,855 sh | 2,960,855 | $262.9M | 0.03% | +85.2% |
| 10 | DRIEHAUS CAPITAL MANAGEMENT#10 · 2,799,166 sh | 2,799,166 | $248.5M | 1.44% | +0.3% |
| 11 | GEODE CAPITAL MANAGEMENT#11 · 2,562,265 sh | 2,562,265 | $239.3M | 0.01% | +48.9% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT#12 · 2,330,098 sh | 2,330,098 | $206.9M | <0.01% | +298.2% |
| 13 | Capital World Investors#13 · 2,315,553 sh | 2,315,553 | $205.6M | 0.02% | +247.4% |
| 14 | Jupiter Topco#14 · 2,206,936 sh | 2,206,936 | $195.9M | 0.08% | — |
| 15 | TCG Crossover Management#15 · 1,900,582 sh | 1,900,582 | $168.7M | 4.06% | 0.0% |
| 16 | TANG CAPITAL MANAGEMENT#16 · 1,892,200 sh | 1,892,200 | $168.0M | 7.63% | 0.0% |
| 17 | BANK OF AMERICA#17 · 1,777,854 sh | 1,777,854 | $157.8M | 0.01% | +44.8% |
| 18 | ADAGE CAPITAL PARTNERS GP, L.L.C.#18 · 1,722,300 sh | 1,722,300 | $152.9M | 0.21% | New |
| 19 | WELLINGTON MANAGEMENT GROUP LLP#19 · 1,581,505 sh | 1,581,505 | $140.4M | 0.02% | -13.3% |
| 20 | GOLDMAN SACHS GROUP#20 · 1,478,059 sh | 1,478,059 | $131.2M | 0.01% | +447.6% |
| 21 | FRANKLIN RESOURCES#21 · 1,472,943 sh | 1,472,943 | $130.8M | 0.03% | +66.8% |
| 22 | Remedium Capital Partners#22 · 1,464,169 sh | 1,464,169 | $130.0M | 28.78% | -23.2% |
| 23 | Affinity Asset Advisors#23 · 1,279,134 sh | 1,279,134 | $113.6M | 5.13% | 0.0% |
| 24 | JPMORGAN CHASE#24 · 1,093,026 sh | 1,093,026 | $98.9M | <0.01% | +11.6% |
| 25 | Holocene Advisors#25 · 1,015,170 sh | 1,015,170 | $90.1M | 0.20% | New |
| 26 | MARSHALL WACE, LLP#26 · 991,693 sh | 991,693 | $88.0M | 0.07% | +612.1% |
| 27 | Polar Capital Plc#27 · 988,009 sh | 988,009 | $87.7M | 0.21% | +24.6% |
| 28 | Siren, L.L.C.#28 · 968,598 sh | 968,598 | $86.0M | 1.74% | +18.3% |
| 29 | Capital International Investors#29 · 955,196 sh | 955,196 | $84.8M | 0.02% | -45.3% |
| 30 | BRAIDWELL#30 · 879,467 sh | 879,467 | $78.1M | 2.89% | -5.7% |
| 31 | Commodore Capital#31 · 846,786 sh | 846,786 | $75.2M | 4.48% | -55.7% |
| 32 | UBS Group AG#32 · 843,071 sh | 843,071 | $74.8M | <0.01% | +25.6% |
| 33 | NORTHERN#33 · 674,529 sh | 674,529 | $59.9M | <0.01% | +16.5% |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT#34 · 652,958 sh | 652,958 | $58.0M | <0.01% | +16.0% |
| 35 | Pictet Asset Management Holding SA#35 · 628,138 sh | 628,138 | $55.8M | 0.05% | +27.8% |
| 36 | EMERALD ADVISERS#36 · 567,430 sh | 567,430 | $50.4M | 1.19% | -7.5% |
| 37 | VICTORY CAPITAL MANAGEMENT#37 · 553,980 sh | 553,980 | $49.2M | 0.03% | +89.6% |
| 38 | VANGUARD FIDUCIARY#38 · 551,389 sh | 551,389 | $49.0M | 0.01% | +18.7% |
| 39 | Candriam S.C.A.#39 · 546,312 sh | 546,312 | $48.5M | 0.22% | -10.5% |
| 40 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#40 · 522,071 sh | 522,071 | $46.3M | <0.01% | +151.8% |
| 41 | MORGAN STANLEY#41 · 499,963 sh | 499,963 | $44.4M | <0.01% | +102.6% |
| 42 | VOYA INVESTMENT MANAGEMENT#42 · 431,694 sh | 431,694 | $38.3M | 0.03% | +699.9% |
| 43 | EMERALD MUTUAL FUND ADVISERS#43 · 401,271 sh | 401,271 | $35.6M | 1.25% | -1.7% |
| 44 | SAMLYN CAPITAL#44 · 400,075 sh | 400,075 | $35.5M | 0.58% | +0.9% |
| 45 | AMERIPRISE FINANCIAL#45 · 356,082 sh | 356,082 | $31.6M | <0.01% | +123.6% |
| 46 | Integral Health Asset Management#46 · 325,000 sh | 325,000 | $28.9M | 1.14% | New |
| 47 | Woodline Partners#47 · 306,049 sh | 306,049 | $27.2M | 0.08% | +15.1% |
| 48 | JENNISON ASSOCIATES#48 · 303,180 sh | 303,180 | $26.9M | 0.02% | New |
| 49 | ADAR1 Capital Management#49 · 283,982 sh | 283,982 | $25.2M | 1.15% | -16.1% |
| 50 | BNP PARIBAS FINANCIAL MARKETS#50 · 259,923 sh | 259,923 | $23.1M | <0.01% | +1295.2% |
| 51 | Bank of New York Mellon#51 · 245,193 sh | 245,193 | $21.8M | <0.01% | +28.1% |
| 52 | Bellevue Group AG#52 · 229,931 sh | 229,931 | $20.4M | 0.43% | New |
| 53 | Cormorant Asset Management#53 · 225,000 sh | 225,000 | $20.0M | 1.02% | New |
| 54 | SEVEN GRAND MANAGERS#54 · 225,000 sh | 225,000 | $20.0M | 0.80% | +125.0% |
| 55 | EVENTIDE ASSET MANAGEMENT#55 · 201,616 sh | 201,616 | $17.9M | 0.24% | New |
| 56 | MILLENNIUM MANAGEMENT#56 · 196,712 sh | 196,712 | $17.5M | <0.01% | +34.1% |
| 57 | ORBIMED ADVISORS#57 · 186,145 sh | 186,145 | $16.5M | 0.31% | New |
| 58 | FRONTIER CAPITAL MANAGEMENT#58 · 182,931 sh | 182,931 | $16.2M | 0.15% | New |
| 59 | Nuveen#59 · 181,105 sh | 181,105 | $16.1M | <0.01% | +17.7% |
| 60 | Neuberger Berman Group#60 · 180,884 sh | 180,884 | $16.1M | 0.01% | New |
| 61 | DEUTSCHE BANK AG\#61 · 174,459 sh | 174,459 | $15.5M | <0.01% | +35.0% |
| 62 | Universal- Beteiligungs- und Servicegesellschaft mbH#62 · 172,923 sh | 172,923 | $15.4M | 0.02% | +1.5% |
| 63 | BALYASNY ASSET MANAGEMENT L.P.#63 · 147,042 sh | 147,042 | $13.1M | 0.02% | +165.1% |
| 64 | Soleus Capital Management, L.P.#64 · 147,000 sh | 147,000 | $13.1M | 0.45% | New |
| 65 | Squarepoint Ops#65 · 139,605 sh | 139,605 | $12.4M | 0.01% | New |
| 66 | ARMISTICE CAPITAL#66 · 137,588 sh | 137,588 | $12.2M | 0.15% | +13.8% |
| 67 | Russell Investments Group, Ltd.#67 · 134,757 sh | 134,757 | $12.0M | 0.01% | +1256.9% |
| 68 | Ensign Peak Advisors#68 · 126,620 sh | 126,620 | $11.2M | 0.02% | -14.8% |
| 69 | Invesco Ltd.#69 · 120,541 sh | 120,541 | $10.7M | <0.01% | -9.0% |
| 70 | Blackstone#70 · 120,177 sh | 120,177 | $10.7M | 0.03% | -59.0% |
| 71 | Rhenman & Partners Asset Management AB#71 · 119,300 sh | 119,300 | $10.6M | 1.00% | New |
| 72 | TD ASSET MANAGEMENT#72 · 115,990 sh | 115,990 | $10.3M | <0.01% | -15.6% |
| 73 | Swiss National Bank#73 · 112,500 sh | 112,500 | $10.0M | <0.01% | +16.6% |
| 74 | StemPoint Capital#74 · 106,926 sh | 106,926 | $9.5M | 1.64% | -36.2% |
| 75 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#75 · 104,516 sh | 104,516 | $9.3M | <0.01% | -7.4% |
| 76 | CITADEL ADVISORS#76 · 103,100 sh | 103,100 | $9.2M | <0.01% | -4.7% |
| 77 | Boxer Capital Management#77 · 100,000 sh | 100,000 | $8.9M | 0.67% | New |
| 78 | RHUMBLINE ADVISERS#78 · 94,763 sh | 94,763 | $8.4M | <0.01% | +11.3% |
| 79 | BARCLAYS PLC#79 · 94,069 sh | 94,069 | $8.4M | <0.01% | +105.5% |
| 80 | F/m Investments#80 · 92,618 sh | 92,618 | $8.2M | 0.42% | -6.9% |
| 81 | PRUDENTIAL FINANCIAL#81 · 87,370 sh | 87,370 | $7.8M | <0.01% | +46.7% |
| 82 | FEDERATED HERMES#82 · 85,950 sh | 85,950 | $7.6M | 0.01% | New |
| 83 | Granahan Investment Management#83 · 82,991 sh | 82,991 | $7.4M | 0.26% | New |
| 84 | CITIGROUP#84 · 82,593 sh | 82,593 | $7.3M | <0.01% | +587.9% |
| 85 | WELLS FARGO & COMPANY#85 · 82,506 sh | 82,506 | $7.3M | <0.01% | +148.5% |
| 86 | HighVista Strategies#86 · 77,807 sh | 77,807 | $6.9M | 1.57% | -46.8% |
| 87 | MERCER GLOBAL ADVISORS#87 · 71,145 sh | 71,145 | $6.3M | <0.01% | +0.1% |
| 88 | B Group#88 · 70,000 sh | 70,000 | $6.2M | 2.92% | -30.0% |
| 89 | Trexquant Investment#89 · 67,007 sh | 67,007 | $5.9M | 0.04% | New |
| 90 | Informed Momentum#90 · 60,393 sh | 60,393 | $5.4M | 0.48% | New |
| 91 | SILVERARC CAPITAL MANAGEMENT#91 · 59,959 sh | 59,959 | $5.3M | 0.55% | -67.9% |
| 92 | PRINCIPAL FINANCIAL GROUP#92 · 59,747 sh | 59,747 | $5.3M | <0.01% | +1289.8% |
| 93 | Hudson Bay Capital Management#93 · 58,387 sh | 58,387 | $5.2M | 0.01% | New |
| 94 | HealthInvest Partners AB#94 · 57,030 sh | 57,030 | $5.1M | 1.36% | -9.1% |
| 95 | RAYMOND JAMES FINANCIAL#95 · 53,627 sh | 53,627 | $4.8M | <0.01% | +171.5% |
| 96 | Susquehanna Portfolio Strategies#96 · 53,101 sh | 53,101 | $4.7M | 0.08% | 0.0% |
| 97 | ALLIANCEBERNSTEIN L.P.#97 · 92,540 sh | 92,540 | $4.7M | <0.01% | +30.5% |
| 98 | ROYCE & ASSOCIATES#98 · 51,789 sh | 51,789 | $4.6M | 0.04% | New |
| 99 | XTX Topco Ltd#99 · 50,483 sh | 50,483 | $4.5M | 0.06% | +106.6% |
| 100 | Monashee Investment Management#100 · 50,000 sh | 50,000 | $4.4M | 7.45% | New |
Funds that sold out of SYRE in Q2 2026 (21)
Held SYRE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.